1. Sehba, F. A., Hou, J., Pluta, R. M., & Zhang, J. H. (2012). The importance of early brain injury after subarachnoid hemorrhage. Progress in Neurobiology, 97, 14–37.
2. Ardelt, A. (2012). From bench-to-bedside in catastrophic cerebrovascular disease: Development of drugs targeting the endothelin axis in subarachnoid hemorrhage-related vasospasm. Neurological Research, 34, 195–210.
3. Gokce, C., Gulsen, S., Yilmaz, C., Guven, G., Caner, H., et al. (2010). The effect of the sildenafil citrate on cerebral vasospasm and apoptosis following experimental subarachnoid hemorrhage in rats. Journal of Neurosurgical Sciences, 54, 29–37.
4. Wang, Y. X., Martin-McNulty, B., da Cunha, V., Vincelette, J., Lu, X., et al. (2005). Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Circulation, 111, 2219–2226.
5. Dreier, J. P., Drenckhahn, C., Woitzik, J., Major, S., Offenhauser, N., et al. (2013). Spreading ischemia after aneurysmal subarachnoid hemorrhage. Acta Neurochirurgica Supplement, 115, 125–129.